Thema: US0042251084
ACAD, US0042251084
bitcoin-6537381_1920.jpg - Foto: THN
ACADIA Pharmaceuticals stock: BofA keeps Buy rating, target at USD 31
BofA Securities kept its Buy rating on ACADIA Pharmaceuticals stock on Wednesday. The target keeps valuation in focus for investors.
ad-hoc-news.de, heute 01:31 Uhr
ACAD, US0042251084
Needham keeps USD 35.00 target for ACADIA Pharmaceuticals ...
ACADIA reported Q2 revenue of USD 308.00 million, up 16.40 percent year over year. ACADIA Pharmaceuticals stock costs EUR 18.07 on October 20, 2026.
ad-hoc-news.de, 20.10.26 18:36 Uhr
ACAD, US0042251084
ACADIA Pharmaceuticals stock has a USD 31.34 consensus target ...
Revenue hit USD 308.00 million, up 16.40 percent year over year. ACADIA Pharmaceuticals stock closed at USD 19.12 on October 16, 2026, down 2.99 percent.
ad-hoc-news.de, 17.10.26 20:08 Uhr
ACAD, US0042251084
UBS cuts target for ACADIA Pharmaceuticals stock to USD ...
Q2 revenue reached USD 308.00 million. ACADIA Pharmaceuticals stock costs EUR 17.55 on October 15, 2026 at 7:41 p.m. CEST.
ad-hoc-news.de, 15.10.26 19:48 Uhr
ACAD, US0042251084
RBC reiterates Outperform on ACADIA Pharmaceuticals stock ...
Revenue hit USD 308.0 million, up 16.00 percent year over year. ACADIA Pharmaceuticals stock costs EUR 18.03 on October 6, 2026 after EUR 17.92.
ad-hoc-news.de, 06.10.26 09:42 Uhr
ACAD, US0042251084
Needham cuts target for ACADIA Pharmaceuticals stock from ...
Q2 revenue rose 16.40 percent to USD 308.00 million. ACADIA Pharmaceuticals stock costs EUR 17.86 versus EUR 17.69 on October 2, 2026.
ad-hoc-news.de, 02.10.26 14:24 Uhr
